ARCHIVES

As ImClone Investigation Continues, FDA Combines Drugs, Biologics Review; Memo Describes “Lengthy Process” That Led To FDA Decision; Oncology Community Praises FDA Move

This article is from The Cancer Letter archive.

Vol. 28 No. 33 | September 13, 2002

Download PDF Visit The Full Archive

Related Articles

FDA Deputy Commissioner Gottlieb To Return To AEI.

December 15, 2006

Stereo Mammography Detects More Lesions, Study Finds

December 28, 2007

NCI Facing Extended Tie Under Acting Director – Maybe

August 19, 1988

University of Oklahoma Wins Planning Grant; Three Mile Island Follow-Up Finds No Significant Increase In Cancer Deaths

November 2, 2002

In Brief: Changes In Key Subcommittee chairmanships, Brooke’s Defeat Leave Direction In Doubt

November 17, 1978

Malone Retires As NIH Deputy, Raub To Succeed Him

August 22, 1986